Skip to Content

Label Changes for:

Lopressor HCT (metoprolol tartrate USP and hydrochlorothiazide USP) Tablets

January 2008

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

Summary View

Sections Modified


  • Drug/Drug Interactions
    • Lopressor
      • Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease
        heart rate. Concomitant use can increase the risk of bradycardia.